Oncopharmpod
Niraparib + Abiraterone, Elranatamab, & Melphalan Updates
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:14:25
- More information
Informações:
Synopsis
A combination product is now available of niraparib + abiraterone for use in mCRPC. Another BCMA-CD3 agent is approved for r/r multiple myeloma and melphalan hepatic arterial infusion for metastatic uveal melanoma is approved.
